Abstract
The group of psychotomimetic agents (also called fantastika, hallucinogens psychedelics, psychodysleptics, and mysticomimetics) plays a double role in our consideration of them. They are not only valuable chemical aids in assisting us to understand the chemistry of the brain and the psychology of mental functioning. In addition, they have presented us with new and expanding medicolegal and sociological problems.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
F. E. Cheek, S. Newell and M. Joffe, Science 167, 1276 (1970).
M. Goldstein, Psychopharm. Rev. 18, 77 (1966).
A. Hofmann, R. Heim, A. Braek and H. Kobel, Experientia 14, 107 (1958).
R. G. Wasson, Harvard Univ. Bot. Mus. Leafl. 19, 137 (1961).
A. Hofmann and A. Cerletti, Deut. Med. Wochenschr. 86, 885 (1961).
S. Cohen, Amer. J. Psychiat. 120, 1024 (1964).
A. D. Marderosian, Amer. J. Pharmacy 139, 20 (1967).
A. Stoll and A. Hofmann, Helv. chim. Acta 26, 94 (1943).
A. Hofmann and H. Tscherter, Experientia 16, 414 (1960).
S. Szara, A Review of Progress 1957–1967, in: Psychopharmacology (Public Health Service Publication No. 1836, Washington 1968), p. 1195.
S. Szara, Am. J. Psychiat. 123, 1513 (1967).
J. M. Saavedra and U. Udabe, Psychosomatics 11, 90 (1970).
L. B. Speck, Doctoral Thesis (Univ. Colorado, Dept. Physiology, Boulder, Col., 1955 ).
N. Neff, G. V. Rossi, G. D. Chase and J. L. Rabinowitz, J. Pharmacol. Exper. Therap. 144, 1 (1964).
K. D. Charalampous, K. E. Walker and V. Kinross-Wright, Psychopharmacologia 9, 48 (1966).
G. K. Aghajanian, M. H. Sheard and W. E. Foote, Psychotomimetic Drugs ( Raven Press, New York 1970 ), p. 165.
S. H. Snyder and C. G. Merrill, Proc. Nat. Acad. Sci. 54, 258 (1965).
S. H. Snyder and E. Richelson, Psychotomimetic Drugs ( Raven Press, New York 1970 ), p. 43.
M. Fujimori and H. E. Himwich, Annual Review of Pharmacology, Vol. 10 ( Annual Reviews, Palo Alto, Calif., 1970 ), p. 325.
A. H. Henderson and D. J. Pugsley, Brit. Med. J. 3, 229 (1968).
A. B. King and D. L. Cowen, J. Amer. Med. Assn. 210, 724 (1969).
M. H. Keeler, Amer. J. Psychiat. 125, 384 (1968).
L. Wurmser, Bull. Problems of Drug Dependence ( NAS-NRC, Washington 1969 ), p. 6154.
J. A. Talbott, Usarv Med. Bull. 40, 7 (1968).
L. M. Zunin, Military Med. 134, 104 (1969).
L. J. West, Meeting on Marihuana and Amphetamines, Salk Institute, La Jolla, Calif., 22–23 Jan. 1970.
A. T. Weil, N. E. Zinberg and J. M. Nelsen, Science 162, 1234 (1968).
A. T. Weil and N. E. Zinberg, Nature 222, 434 (1969).
F. Ames, J. Ment. Sci. 104, 972 (1958).
J. R. Tinklenberg, F. T. Melges, L. E. Hollister and H. K. Gillespie, Science 168, 118 (1970).
L. D. Clark, R. Hughes and E. Nakashima, Meeting on Marihuana and Amphetamines, Salk Institute, La Jolla, Calif., 22–23 Jan. 1970.
R. T. Jones, E. Calloway and E. Donchin, J. Biol. Psychiat. (1970).
A. Crancer, J. M. Dille, J. C. Delay, J. E. Wallace and M. D. Haykin, Science 164, 851 (1969).
R. Mechoulam and Y. Gaoni, Fortschr. Chem. Org. Naturst. 25, 175 (1967).
R. Mechoulam, Science 168, 3936 (1970).
R. Adams, Harvey Lecture Series 37, 168 (1941-1942).
T. Petrzilka and C. Sikemeier, Helv. Chim. Acta 50, 2111 (1967).
R. L. Foltz, A. F. Fentiman, E. G. Leighty, J. L. Walter, H. R. Drewes, W. E. Schwartz, T. F. Page and E. B. Truitt, Science 168, 844 (1970).
S. H. Burstein, F. Menezes, E. Williamson and R. Mechoulam, Nature 225, 87 (1970).
I. M. Nilsson, S. Agurell, J. L. G. Nilsson, A. Ohlsson, F. Sandberg and W. Wahlqvist, Science 168, 3936 (1970).
Y. Grunfeld and H. Edery, Pyschopharmacologia 14, 200 (1969).
J. Idanpaan-Heikkila, G. E. Fritchie, L. F. Englert, B. T. Ho and W. M. Mcissac, New Eng. J. Med., 281, 330 (1969).
S. Agurell, The Botany and Chemistry of Cannabis and its Derivatives (Ciba Foundation, Random, London 1969 ).
R. N. Phillips, R. F. Turk and R. B. Forney, Presented at the Ninth Annual Meeting of the Society of Toxicology, Atlanta, Georgia, 15–19 March 1970.
G. Francois, E. Barratt, G. Russell, T. Baker and R. B. White, Read at the American Psychiatric Assn. Meeting (Honolulu, Hawaii, 19 May 1970 ).
H. Isbell, C. W. Gorodetsky, D. Jasinski, U. Claussen, F. V. Spulak and F. Korte, Psychopharmacologia 11, 184 (1967).
L. E. Hollister, Chemical Psychoses (Thomas, Springfield, Illinois 1968 ).
F. J. Bullock, R. J. Bruni and E. Werner. TO be published.
L. G. Abood and J. H. Biel, Intern. Rev. Neurobiol. 4, 217 (1962).
N. Giarman, Fed. Proc. 22, 215 (1963).
T. G. Lawes, Brit. J. Psychiat. 109, 243 (1963).
L. J. West and C. M. Pierce, Science 138, 1100 (1962).
W. P. Koella, R. F. Beaulieu and J. Bergen, Intern. J. Neuropharmacol. 3, 397 (1964).
D. E. Rosenberg, A. B. Wolbach, E. J. Miner and H. Isbell, Psychopharmacologia 5, 1 (1963).
G. K. Aghajanian and O. H. L. Bing, Clin. Pharmacol. Therap. 5, 611 (1964).
S. H. Snyder and M. Revich, Nature 209, 1093 (1966).
D. W. Wooley and E. Shaw, Proc. Nat. Acad. Sci. U.S. 40, 228 (1954).
R. M. Marchbanks, F. Rosenblatt and R. D. O’Brien, Science 144, 1135 (1964).
D. X. Freedman, Amer. J. Psychiat. 191, 843 (1963).
D. X. Freedman, Annual Review of Medicine ( Annual Reviews, Palo Alto, Calif., 1969 ), p. 409.
D. V. Siva-Sankar, Upstate Hosp. Conf. Dept. Mental Hygiene (N.Y. State, 29 April 1963 ).
O. Resnick, D. M. Krus and M. Raskin, Life Sci. 3, 1207 (1964).
K. Nandy and G. H. Bourne, J. Neurol. Neurosurg. Psychiat. 27, 259 (1964).
P. M. Diaz, S. H. Ngai and E. Costa, Advan. Pharmacol. 6B, 75 (1968).
N. E. Anden, H. Corrodi, K. Fuxe and T. Hokfelt, Brit. J. Pharmacol. Chemoter. 34, 1 (1968).
R. C. Lin, S. H. Ngai and E. Costa, Science 166, 237 (1969).
M. M. Cohen, K. Hirschhorn and W. A. Frosch, New Engl. J. Med. 277, 1043 (1967).
R. Auerbach and J. A. Rugowski, Science 157, 1325 (1967).
J. A. Di Paolo and G. J. Alexander, Science 158, 522 (1967).
S. Irwin and J. Egozcue, Science 157, 313 (1967).
S. Irwin and J. Egozcue, Science 159, 749 (1968).
H. Zellweger, J. S. Mcdonald and G. Abbo, Lancet 2, 1306 (1967).
R. S. Sparkes, D. Thomas and J. Melnyk, Science 162, 1509 (1968).
F. W. Whitmore, Science 162, 1508 (1968).
R. G. Smart and K. Bateman, Canad. Med. Assn. J. 99, 805 (1968).
W. H. Krusal and S. Haberman, Science 162, 1508 (1968).
J. Warkany and E. Takacs, Science 159, 731 (1968).
D. A. Hungerford, K. M. Taylor and C. Shagass, J. Amer. Med. Assn. 206, 2287 (1968).
L. Bender and D. V. Sankar, Science 159, 749 (1968).
W. F. Geber, Science 158, 265 (1967).
J. K. Hanaway, Science 164, 574 (1969).
R. Denson, Canad. Med. Assn. J. 98, 609 (1968).
H. M. Slatis, Science 159, 1492 (1968).
N. E. Skakkbaek, J. Philipp and O. J. Rafaelsen, Science 160, 1246 (1968).
J. Nielsen, U. Friedrich and E. Jacobsen, Ugeskrift Laeger 130, 1381 (1968).
W. D. Loughman, T. W. Sargent and D. M. Israelstam, Science 158, 508 (1967).
W. D. Loughman and T. W. Sargent, Science 159, 1493 (1968).
L. S. Browning, Science 161, 1022 (1968).
P. H. Fitzgerald, New Engl. J. Med. 278, 1404 (1968).
P. H. Fitzgerald and J. R. Dobson, Lancet 1, 1036 (1968).
J. A. Di Paolo, H. M. Givelber and H. Erwin, Nature 220, 490 (1968).
J. E. Idänpään-Heikkilä and J. C. Schoolar, Science 164, 1295 (1969).
C. B. Jacobson and V. L. Magyar, Clin. Proc. Children’s Hosp. Dist. Columbia 24, 153 (1968).
O. M. Garson and M. K. Robson, Brit. Med. J. 2, 800 (1969).
S. S. Epstein and J. Lederberg, Science 168, 507 (1970).
J. Axelrod, R. O. Brady, B. Witkop and E. V. Evarts, Ann. N. Y. Acad. Sci. 66, 435 (1957).
S. Szara, Life Sci. 9, 662 (1963).
E. V. Evarts, Ann. N.Y. Acad. Sci. 66, 479 (1957).
E. Hartmann, Psychon. Sci. 8, 295 (1967).
J. A. Hobson, Enceph. clin. Neurophysiol. 11, 52 (1964).
W. R. Adey, F. R. Bell and B. J. Denni, Neurology 12, 591 (1962).
W. R. Adey, R. Porter, D. O. Walter and T. S. Brown, Electroenceph. clin. Neurophysiol. 18, 24 (1965).
T. M. Glenn and V. A. Green, Psychopharmacologist 6, 191 (1964).
S. Cohen, The Beyond Within: The LSD Story ( Atheneum, New York 1964 ).
A. E. Edwards and S. Cohen, Psychopharmacologia 2, 297 (1961).
L. Fichman, B. G. Eisner and S. Cohen, Amer. J. Psychiat. 115, 30 (1958).
H. A. Abramson, M. E. Jarvik, M. R. Kaufman, C. Kornetsky, C. Levine and M. Wagner, J. Psychol. 39, 3 (1955).
H. Leuner, in: The Use of LSD in Psychotherapy and Alcoholism ( Bobbs-Merrill, Indianapolis 1967 ), p. 101.
S. Unger, in: Psychedelic Drugs ( Grüne & Stratton, New York 1969 ) p. 199.
A. M. Ludwig and J. Levine, Amer. J. Psychother. 19, 417 (1965).
S. Cohen, J. Nerv. Ment. Dis. 130, 30 (1960).
S. Cohen, Psychosomatics 12, 182 (1966).
H. J. Widroe, Clin. Toxicol. 1, 179 (1968).
S. Cohen, Drug Dependence 2, 1 (1970).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1971 Birkhäuser Verlag Basel
About this chapter
Cite this chapter
Cohen, S. (1971). The Psychotomimetic Agents. In: Jucker, E. (eds) Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des Recherches Pharmaceutiques. Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des Recherches Pharmaceutiques, vol 15. Birkhäuser Basel. https://doi.org/10.1007/978-3-0348-7078-8_2
Download citation
DOI: https://doi.org/10.1007/978-3-0348-7078-8_2
Publisher Name: Birkhäuser Basel
Print ISBN: 978-3-0348-7080-1
Online ISBN: 978-3-0348-7078-8
eBook Packages: Springer Book Archive